Group One Trading, L.P. Verrica Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.74 - $6.81 $16,125 - $23,167	-3,402 Reduced 82.98%	698 $4,000
Q4 2023 Feb 14, 2024	SELL	$2.93 - $7.32 $28,356 - $70,842	-9,678 Reduced 70.24%	4,100 $30,000
Q3 2023 Nov 09, 2023	BUY	$3.75 - $7.46 $51,667 - $102,783	13,778 New	13,778 $53,000
Q4 2022 Feb 09, 2023	SELL	$2.09 - $3.39 $1,839 - $2,983	-880 Reduced 19.13%	3,720 $10,000
Q3 2022 Nov 09, 2022	BUY	$2.17 - $4.3 $8,463 - $16,770	3,900 Added 557.14%	4,600 $13,000
Q2 2022 Aug 11, 2022	BUY	$1.81 - $8.93 $905 - $4,465	500 Added 250.0%	700 $1,000
Q1 2022 May 12, 2022	BUY	$7.59 - $9.49 $759 - $949	100 Added 100.0%	200 $2,000
Q4 2021 Feb 11, 2022	SELL	$9.1 - $13.36 $2,730 - $4,008	-300 Reduced 75.0%	100 $1,000
Q3 2021 Nov 12, 2021	BUY	$9.55 - $13.96 $3,820 - $5,584	400 New	400 $5,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.